3-aminobenzamide has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is a DNA-methylating agent used in the treatment of malignant gliomas." | 1.33 | Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. ( Ali-Osman, F; Bigner, DD; Cheng, CL; Dolan, ME; Friedman, HS; Johnson, SP; Keir, ST; Li, H; Modrich, P; Quinn, JA; Salzman, AL; Szabo, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, CL | 1 |
| Johnson, SP | 1 |
| Keir, ST | 1 |
| Quinn, JA | 1 |
| Ali-Osman, F | 1 |
| Szabo, C | 1 |
| Li, H | 1 |
| Salzman, AL | 1 |
| Dolan, ME | 1 |
| Modrich, P | 1 |
| Bigner, DD | 1 |
| Friedman, HS | 1 |
1 other study available for 3-aminobenzamide and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Pair Mismatch; Dacarbazine; DNA Repair; Drug Resist | 2005 |